Dose of zinc boosts recovery chances for sick babies

May 31, 2012

A simple, cheap dose of zinc helps the recovery of newborns suffering from bacterial infections such as pneumonia and meningitis, according to an Indian study reported on Thursday in The Lancet.

Doctors gave 10-milligram daily supplements of zinc to 332 babies who were being given at hospitals in New Delhi, and compared the outcome against 323 infants who were given a placebo as well as antibiotics.

The three-year probe, running from 2005 to 2008, focussed on babies aged between one week and four months.

Compared to the non-zinc group, children who were given the supplements were 40-percent less likely to experience .

This was defined as needing a second course of antibiotics within a week or intensive care, or culminating in death, the study found.

In the zinc group, 34 treatment failures occurred, compared to 55 in the .

Use of zinc also reduced the number of deaths, but not by a margin considered statistically significant.

"Zinc is an accessible, low-cost intervention that could add to the effect of antibiotic treatment and lead to substantial reductions in ," said lead researcher Shinjini Bhatnagar from the All India Institute of Medical Sciences.

The benefit would be highest in developing countries where several million children die from infection each year and where second-line antibiotics and intensive care may be unavailable, he said.

Zinc can be easily administered, either as a syrup or as a soluble tablet, according to the investigation.

Previous research has found that help cure diarrhoea and pneumonia in small children younger than five years old.

Still unclear is why zinc works. One theory is that the mineral has a moderating influence on the immune system, preventing over-inflammation that disrupts drug therapy and leads to .

Explore further: Pneumonia wonder drug: Zinc saves lives

Related Stories

Pneumonia wonder drug: Zinc saves lives

February 8, 2012

Respiratory tract infections, including pneumonia, are the most common cause of death in children under the age of five. In a study looking at children given standard antibiotic therapy, new research published in BioMed Central's ...

Zinc lozenges may shorten common-cold duration

July 26, 2011

Depending on the total dosage of zinc and the composition of lozenges, zinc lozenges may shorten the duration of common cold episodes by up to 40%, according to a study published in the Open Respiratory Medicine Journal.

Zinc lozenges may shorten common cold duration

August 16, 2011

Depending on the total dosage of zinc and the composition of lozenges, zinc lozenges may shorten the duration of common cold episodes by up to 40%, says Dr. Harri Hemila from the University of Helsinki.

Recommended for you

Zika in fetal brain tissue responds to a popular antibiotic

November 30, 2016

Working in the lab, UC San Francisco researchers have identified fetal brain tissue cells that are targeted by the Zika virus and determined that azithromycin, a common antibiotic regarded as safe for use during pregnancy, ...

Zika and glaucoma linked for first time in new study

November 30, 2016

A team of researchers in Brazil and at the Yale School of Public Health has published the first report demonstrating that the Zika virus can cause glaucoma in infants who were exposed to the virus during gestation.

Flu forecasts successful on neighborhood level

November 30, 2016

Scientists at Columbia University's Mailman School of Public Health developed a computer model to predict the onset, duration, and magnitude of influenza outbreaks for New York City boroughs and neighborhoods. They found ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.